This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval of a clarification of the definition of serious adverse events.
Device | HYLAFORM (HYLAN B GEL), HYLAFORM PLUS, CAPTIQUE |
Generic Name | Implant, Dermal, For Aesthetic Use |
Applicant | GENZYME BIOSURGERY |
Date Received | 2006-01-27 |
Decision Date | 2006-02-28 |
PMA | P030032 |
Supplement | S005 |
Product Code | LMH |
Advisory Committee | General & Plastic Surgery |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Postapproval Study Protocol - Ode/oir |
Expedited Review | No |
Combination Product | No |
Applicant Address | GENZYME BIOSURGERY 55 Cambridge Parkway cambridge, MA 02142 |
Supplement Number | Date | Supplement Type |
---|---|---|
P030032 | Original Filing | |
S017 | 2014-08-08 | 30-day Notice |
S016 | 2013-09-25 | 135 Review Track For 30-day Notice |
S015 | ||
S014 | 2011-12-20 | 135 Review Track For 30-day Notice |
S013 | 2011-09-02 | 30-day Notice |
S012 | 2011-05-27 | Real-time Process |
S011 | ||
S010 | 2010-06-09 | 135 Review Track For 30-day Notice |
S009 | 2009-09-11 | 30-day Notice |
S008 | 2009-04-15 | Normal 180 Day Track No User Fee |
S007 | 2007-07-25 | Normal 180 Day Track |
S006 | ||
S005 | 2006-01-27 | Normal 180 Day Track No User Fee |
S004 | 2005-09-23 | Real-time Process |
S003 | 2005-04-20 | Normal 180 Day Track No User Fee |
S002 | 2004-07-28 | Normal 180 Day Track |
S001 | 2004-06-22 | Panel Track |